Introducing Twelve Converter! Real-time currency rates at your fingertips. Available on Android, iOS soon!

INSM

99.94 USD
0.45
0.45%
Last update Jun 30, 11:31 AM EDT
Main market
Day range
99.82
101.52
Previous close
99.49000
Open
100.045
Access this stock data via API
Subscribe
Insmed Inc.
99.94
0.45
0.45%

Overview

Description

Insmed Inc. is a biopharmaceutical company dedicated to enhancing the lives of patients with rare diseases. The company's primary focus is on the development and commercialization of treatments for serious and rare disorders, particularly in the fields of pulmonology and infectious diseases. One of Insmed's noteworthy products is Arikayce, an inhaled antibiotic that addresses specific pulmonary infections often affecting patients with underlying lung conditions. Insmed Inc. also undertakes robust research and development efforts to boost its pipeline of potential therapies, aiming to address unmet medical needs. Operating within the broader healthcare sector, Insmed is a key player in the biopharmaceutical landscape, driven by innovation and scientific research. The company’s continued advancements and strategic collaborations underscore its commitment to elevating patient care and expanding treatment options for rare disease patients. This aligns Insmed as a significant entity in the realm of specialized healthcare solutions, reflecting its impact on the biopharmaceutical market.

About

CEO
Mr. William H. Lewis J.D., M.B.A.
Employees
1271
Address
700 US Highway 202/206
Bridgewater, 08807, NJ
United States
Phone
908 977 9900
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
XNGS
Main market

Exchange is currently active.
Closing in 4 hours 27 minutes

11:32
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).